Published in Medical Letter on the CDC and FDA, April 11th, 2000
"Community-acquired MRSA (CA-MRSA) is potentially a new emerging pathogen, with recent reports coming from the North-Central U.S. and Western Australia. Most of these strains are unique in that they are susceptible to many antimicrobials except (beta)-lactams," reported N. Suntharam and colleagues from Northwestern University Medical School, Illinois.
The researchers reviewed clindamycin-susceptible MRSA isolates during a 20-month study period that lasted from January 1998 to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.